Home
/
PLIANT THERAPEUTICS, INC.
/
Financials
/
Quarterly
PLIANT THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PLIANT THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$0
Nov 7, 2024
Q2
2024
Jun 30, 2024
$0
Aug 7, 2024
Q1
2024
Mar 31, 2024
$0
May 6, 2024
Q3
2024
Sep 30, 2023
$0
Nov 7, 2024
Q2
2024
Jun 30, 2023
$248.0K
Aug 7, 2024
Q1
2024
Mar 31, 2023
$1.33M
May 6, 2024
Q3
2023
Sep 30, 2022
$1.48M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$4.99M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$1.25M
May 9, 2023
Q3
2022
Sep 30, 2021
$1.61M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$1.79M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$2.17M
May 9, 2022
Q3
2021
Sep 30, 2020
$4.81M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$3.60M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$28.94M
May 10, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($26.30M)
Nov 6, 2025
Q3
2025
Jun 30, 2025
($43.30M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($43.30M)
Aug 7, 2025
Q2
2025
Mar 31, 2025
($56.17M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($56.17M)
May 8, 2025
Q3
2025
Mar 31, 2025
($56.17M)
Nov 6, 2025
Q3
2025
Sep 30, 2024
($57.76M)
Nov 6, 2025
Q3
2025
Jun 30, 2024
($55.85M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($55.85M)
Aug 7, 2025
Q2
2025
Mar 31, 2024
($46.96M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($46.96M)
Nov 6, 2025
Q1
2025
Mar 31, 2024
($46.96M)
May 8, 2025
Q3
2024
Sep 30, 2023
($41.49M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($41.19M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($41.19M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($37.55M)
May 6, 2024
Q2
2024
Mar 31, 2023
($37.55M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($37.55M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($30.62M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($29.55M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($28.27M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($45.59M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($58.94M)
May 8, 2025
Q3
2025
Sep 30, 2024
($62.01M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($60.64M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($52.39M)
May 8, 2025
Q3
2024
Sep 30, 2023
($47.69M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($47.33M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($42.10M)
May 6, 2024
Q3
2023
Sep 30, 2022
($31.95M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($29.64M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($28.21M)
May 9, 2023
Q3
2022
Sep 30, 2021
($27.11M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($22.90M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($22.92M)
May 9, 2022
Q3
2021
Sep 30, 2020
($16.66M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($16.98M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
$11.01M
May 10, 2021
Q3
2020
Sep 30, 2019
($13.36M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($15.74M)
Aug 11, 2020